SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aimei Health Technology Co., Ltd (AFJK) trades at a trailing P/E of 135.0. Trailing earnings yield is 0.74%. PEG 0.07 (Peter Lynch undervalued ≤1.0). Graham Number is $9.12.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 135.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.74%).
- PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 0.74% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AFJK
Valuation Multiples
P/E (TTM)135.0
Forward P/EN/A
PEG Ratio0.07
Forward PEGN/A
P/B Ratio4.52
P/S Ratio0.00
EV/EBITDA639.9
Per Share Data
EPS (TTM)$0.35
Book Value / Share$10.51
Revenue / Share$0.00
FCF / Share$-0.18
Yields & Fair Value
Earnings Yield0.74%
Dividend Yield0.00%
Graham Number$9.12
SharesGrow IV$8.95 (-82.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2023 |
534.5 |
0.00 |
1.31 |
0.00 |
- |
| 2024 |
37.8 |
0.03 |
1.34 |
0.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2023 |
$0.02 |
$0.00 |
$171.39K |
- |
| 2024 |
$0.37 |
$0.00 |
$2.55M |
- |
